Benchmark downgraded shares of Select Medical (NYSE:SEM – Free Report) from a buy rating to a hold rating in a research note published on Monday morning, Marketbeat.com reports.
Several other equities analysts have also weighed in on SEM. Royal Bank of Canada increased their price objective on Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a report on Monday, November 4th. Bank of America started coverage on Select Medical in a research note on Tuesday, August 20th. They set a “buy” rating and a $42.00 price target for the company. Finally, StockNews.com downgraded shares of Select Medical from a “buy” rating to a “hold” rating in a report on Thursday, November 21st. Three equities research analysts have rated the stock with a hold rating and two have issued a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and an average price target of $40.75.
View Our Latest Stock Report on SEM
Select Medical Trading Down 4.6 %
Select Medical (NYSE:SEM – Get Free Report) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 EPS for the quarter, topping the consensus estimate of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The business had revenue of $1.76 billion for the quarter, compared to analyst estimates of $1.74 billion. During the same quarter in the previous year, the firm posted $0.46 earnings per share. The company’s revenue for the quarter was up 5.7% on a year-over-year basis. Equities research analysts predict that Select Medical will post 2.16 EPS for the current year.
Select Medical Dividend Announcement
The business also recently declared a quarterly dividend, which was paid on Tuesday, November 26th. Stockholders of record on Wednesday, November 13th were given a $0.125 dividend. This represents a $0.50 annualized dividend and a dividend yield of 2.46%. The ex-dividend date of this dividend was Wednesday, November 13th. Select Medical’s dividend payout ratio (DPR) is presently 23.36%.
Institutional Inflows and Outflows
A number of hedge funds have recently added to or reduced their stakes in SEM. Vanguard Group Inc. boosted its position in shares of Select Medical by 5.3% in the first quarter. Vanguard Group Inc. now owns 12,997,891 shares of the health services provider’s stock valued at $391,886,000 after acquiring an additional 650,093 shares during the period. O Shaughnessy Asset Management LLC boosted its holdings in Select Medical by 12.9% in the 1st quarter. O Shaughnessy Asset Management LLC now owns 20,269 shares of the health services provider’s stock valued at $611,000 after purchasing an additional 2,313 shares during the period. CANADA LIFE ASSURANCE Co increased its holdings in shares of Select Medical by 3.8% in the first quarter. CANADA LIFE ASSURANCE Co now owns 98,657 shares of the health services provider’s stock worth $2,972,000 after purchasing an additional 3,594 shares during the period. BOKF NA purchased a new stake in shares of Select Medical in the first quarter worth $262,000. Finally, Tidal Investments LLC bought a new stake in Select Medical during the first quarter valued at $467,000. Hedge funds and other institutional investors own 89.48% of the company’s stock.
Select Medical Company Profile
Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.
Featured Stories
- Five stocks we like better than Select Medical
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- What Are the U.K. Market Holidays? How to Invest and Trade
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Conference Calls and Individual Investors
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.